Ocugen, Inc. (NASDAQ:OCGN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 5, 2025 Ocugen, Inc. reports earnings inline with expectations. Reported EPS is $-0.05 ...
Ocugen (OCGN) Q4 2024 Earnings Call Transcript
Ocugen ( OCGN -3.41%) Q4 2024 Earnings Call Mar 05, 2025, 8:30 a.m. ET ...
TMCnet4d
Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results
Ocugen has scheduled a conference call and webcast for 8:30 a.m. ET today to discuss the financial results and recent business highlights. Ocugen’s leadership team will host the call, which will be ...
ophthalmologytimes24d
Companies results of the combination of Topcon's retinal camera and AEYE Diagnostic Screening
The combination of Topcon's NW500 and AEYE-DS achieved 100% imageability and high diagnostic accuracy, with 92% sensitivity and 90% specificity. Over 99% of participants were successfully imaged on ...
Yahoo Finance27d
Ocugen, Inc. (OCGN)
“OCU200 has the potential to change the treatment landscape for DME, diabetic retinopathy (DR), and wet age-related macular degenerati OCU410 has a very favorable safety and tolerability profileNo ...